Miromatrix rallies after NYU Langone touts engineered pig kidney transplant

Surgeons at NYU Langone Health have transplanted a genetically engineered pig kidney that continues to function well after 32 days in a man declared dead by neurologic criteria and maintained with a beating heart on ventilator support, the organization said in a statement. “This represents the longest period that a gene-edited pig kidney has functioned in a human, and the latest step toward the advent of an alternate, sustainable supply of organs for transplant,” according to NYU Langone Health. Shares of Miromatrix Medical are up 13% to $1.49 following the announcement. The company has developed a perfusion technology platform for bioengineering organs.